Los Angeles Capital Management LLC Edwards Lifesciences Corp Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$84.3 - $94.31 $364,681 - $407,985	-4,326 Reduced 51.38%	4,094 $378,000
Q1 2024 Apr 05, 2024	SELL	$72.54 - $95.56 $4,279 - $5,638	-59 Reduced 0.7%	8,420 $804,000
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $6.38 Million - $8.04 Million	-103,351 Reduced 92.42%	8,479 $646,000
Q3 2023 Nov 06, 2023	BUY	$69.28 - $93.38 $846,324 - $1.14 Million	12,216 Added 12.26%	111,830 $7.75 Million
Q2 2023 Aug 03, 2023	BUY	$81.41 - $94.33 $486,831 - $564,093	5,980 Added 6.39%	99,614 $9.4 Million
Q1 2023 May 04, 2023	SELL	$74.26 - $84.51 $267,930 - $304,912	-3,608 Reduced 3.71%	93,634 $7.75 Million
Q4 2022 Feb 06, 2023	SELL	$68.3 - $87.44 $428,241 - $548,248	-6,270 Reduced 6.06%	97,242 $7.26 Million
Q3 2022 Nov 02, 2022	BUY	$82.37 - $107.29 $4.55 Million - $5.93 Million	55,291 Added 114.66%	103,512 $8.55 Million
Q2 2022 Aug 05, 2022	BUY	$86.5 - $128.27 $1.11 Million - $1.64 Million	12,819 Added 36.21%	48,221 $4.59 Million
Q1 2022 May 06, 2022	SELL	$101.96 - $128.34 $7.56 Million - $9.51 Million	-74,110 Reduced 67.67%	35,402 $4.17 Million
Q4 2021 Feb 03, 2022	SELL	$106.37 - $130.68 $2.65 Million - $3.26 Million	-24,912 Reduced 18.53%	109,512 $14.2 Million
Q3 2021 Nov 08, 2021	SELL	$102.91 - $122.75 $418,432 - $499,101	-4,066 Reduced 2.94%	134,424 $15.2 Million
Q2 2021 Aug 05, 2021	BUY	$83.84 - $104.76 $20,540 - $25,666	245 Added 0.18%	138,490 $14.3 Million
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $64.1 Million - $73.8 Million	-814,073 Reduced 85.48%	138,245 $11.6 Million
Q4 2020 Feb 04, 2021	SELL	$71.69 - $91.23 $1.83 Million - $2.32 Million	-25,472 Reduced 2.61%	952,318 $86.9 Million
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $3.54 Million - $4.6 Million	-52,647 Reduced 5.11%	977,790 $78 Million
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $40.1 Million - $53.7 Million	697,495 Added 209.49%	1,030,437 $71.2 Million
Q1 2020 May 04, 2020	BUY	$52.41 - $81.0 $1.23 Million - $1.9 Million	23,479 Added 7.59%	332,942 $62.8 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $416,003 - $476,286	-5,802 Reduced 1.84%	309,463 $72.2 Million
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $7.33 Million - $8.98 Million	119,019 Added 60.65%	315,265 $69.3 Million
Q2 2019 Jul 29, 2019	SELL	$55.74 - $64.41 $58,749 - $67,888	-1,054 Reduced 0.53%	196,246 $36.3 Million
Q1 2019 Apr 25, 2019	BUY	$47.89 - $64.05 $5.49 Million - $7.34 Million	114,660 Added 138.75%	197,300 $37.7 Million
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $7.66 Million - $9.39 Million	-164,964 Reduced 66.62%	82,640 $12.7 Million
Q3 2018 Nov 05, 2018	BUY	$45.7 - $58.03 $135,272 - $171,768	2,960 Added 1.21%	247,604 $43.1 Million
Q2 2018 Jul 31, 2018	BUY	$42.45 - $51.3 $537,247 - $649,252	12,656 Added 5.46%	244,644 $35.6 Million
Q1 2018 Apr 27, 2018	BUY	$37.19 - $47.45 $213,284 - $272,125	5,735 Added 2.53%	231,988 $32.4 Million
Q4 2017 Feb 05, 2018	SELL	$33.79 - $39.39 $591,730 - $689,797	-17,512 Reduced 7.18%	226,253 $25.5 Million
Q3 2017 Nov 06, 2017	SELL	$36.29 - $38.83 $113,369 - $121,304	-3,124 Reduced 1.27%	243,765 $26.6 Million
Q2 2017 Aug 09, 2017	BUY	N/A	246,889	246,889 $29.2 Million

Others Institutions Holding EW

# of Institutions

1,352

Shares Held

469M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.45 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.63 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.24 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.87 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$962 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account